Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy
Clinical trial NCT01261143 · COMPLETED
Trial details
- NCT number
- NCT01261143
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-04-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.